UC researchers open Phase 2 clinical trial to test new combination treatment for glioblastomas

WASHINGTON — Tuesday’s Senate Finance Committee hearing on how the Dobbs decision affected women’s access to care featured arguments over everything — including the title

As the fifth ma­jor phar­ma play­er to stake a claim in ra­dio­phar­ma­ceu­ti­cals, As­traZeneca sees big po­ten­tial in im­prov­ing on cur­rent op­tions and ex­plor­ing com­bi­na­tion can­cer